Results 51 to 60 of about 100,711 (219)
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score
Annals of Neurology, 2022 This study aimed to validate the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score in the International Guillain–Barré Syndrome Outcome Study cohort, and to improve its performance and region‐specificity.
A. Y. Doets +11 more
semanticscholar +1 more source
Guillain–Barre syndrome after myocardial infarction: a case report and literature review
BMC Cardiovascular Disorders, 2023 Background Guillain–Barre syndrome after myocardial infarction occurs infrequently, and its occurrence following percutaneous coronary intervention is extremely rare.
Pu-yuan Wen +5 more
doaj +1 more source
Guillain-Barré syndrome in temporal association with influenza A vaccine [PDF]
, 2011 OBJECTIVE: To report a case of Guillain-Barré syndrome following influenza A (H1N1) 2009 vaccine. CASE DESCRIPTION: A four-year-old boy presented right thigh pain and ascending muscular weakness 15 days after the second dose of influenza A (H1N1) 2009 ...
Ferrarini, Maria Aparecida G +5 more
core +3 more sources
Intact thumb reflex in areflexic Guillain Barré syndrome: A novel phenomenon
Annals of Indian Academy of Neurology, 2014 Introduction: Areflexia is one of the cardinal clinical features for the diagnosis of Guillain Barré syndrome. However, some patients may have sluggish proximal muscle stretch reflexes.
Karkal Ravishankar Naik +2 more
doaj +1 more source
Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS [PDF]
, 2016 Treatment of Guillain-Barré syndrome with a standard course of high-dose intravenous immunoglobulin (IVIg) results in a variable clinical recovery which is associated with changes in serum IgG levels after treatment. The neonatal Fc-receptor protects IgG
Doorn, P.A. (Pieter) van +6 more
core +1 more source
Emerging Infection, Vaccination, and Guillain–Barré Syndrome: A Review
Neurological Therapeutics, 2021 Guillain–Barré syndrome (GBS) is an autoimmune disorder of the peripheral nervous system that typically develops within 4 weeks after infection. In addition to conventional infectious diseases with which we are familiar, emerging infectious diseases ...
H. Koike, A. Chiba, M. Katsuno
semanticscholar +1 more source
Case Reports in Transplantation, 2017 Guillain-Barré Syndrome (GBS) is a common acute autoimmune polyneuropathy in adults. There have been few reported cases of Guillain-Barré Syndrome associated with active cytomegalovirus (CMV) infection in renal transplant recipients.
Massini Merzkani +2 more
doaj +1 more source
Plasmaferesis Sebagai Terapi Sindrom Guillain-Barre Berat pada Anak
Sari Pediatri, 2016 Plasmaferesis atau plasma exchange merupakan salah satu pilihan terapi bagi sindrom Guillain-Barre berat. Beberapa penelitian menunjukkan bahwa plasmaferesis dan imunoglobulin intravena (IVIg) sebagai terapi sindrom Guillain-Barre memiliki efektivitas ...
Vimaladewi Lukito +3 more
doaj +1 more source
Swallowing impairment in neurologic disorders : the role of videofluorographic swallowing study [PDF]
, 2018 Patients with neurologic diseases almost inevitably develop various degrees of swallowing disorders during their life. Dysphagia is one of the main negative prognostic factors in this class of patients, leading to severe morbidity (i.e.
core +1 more source
Neurological Sciences, 2020 Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy associated with dysimmune processes, often related to a previous infectious exposure.
D. Ottaviani +7 more
semanticscholar +1 more source